Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

The anti-migraine component of butterbur extracts, isopetasin, desensitizes peptidergic nociceptors by acting on TRPA1 cation channel.

Benemei S, De Logu F, Li Puma S, Marone IM, Coppi E, Ugolini F, Liedtke W, Pollastro F, Appendino G, Geppetti P, Materazzi S, Nassini R.

Br J Pharmacol. 2017 Sep;174(17):2897-2911. doi: 10.1111/bph.13917. Epub 2017 Jul 20.

PMID:
28622417
2.

Prophylactic Treatment of Migraine.

Gürsoy AE, Ertaş M.

Noro Psikiyatr Ars. 2013 Aug;50(Suppl 1):S30-S35. doi: 10.4274/npa.y7199. Epub 2013 Aug 1. Review.

3.

Evidence-Based Treatments for Adults with Migraine.

Gooriah R, Nimeri R, Ahmed F.

Pain Res Treat. 2015;2015:629382. doi: 10.1155/2015/629382. Epub 2015 Dec 29. Review.

4.

The optimal management of headaches in children and adolescents.

Kacperski J, Kabbouche MA, O'Brien HL, Weberding JL.

Ther Adv Neurol Disord. 2016 Jan;9(1):53-68. doi: 10.1177/1756285615616586. Review.

5.

Preventive treatment in migraine and the new US guidelines.

Estemalik E, Tepper S.

Neuropsychiatr Dis Treat. 2013;9:709-20. doi: 10.2147/NDT.S33769. Epub 2013 May 17.

6.

P/Q-type calcium channel modulators.

Nimmrich V, Gross G.

Br J Pharmacol. 2012 Oct;167(4):741-59. doi: 10.1111/j.1476-5381.2012.02069.x. Review.

7.

Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.

Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E; Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.

Neurology. 2012 Apr 24;78(17):1346-53. doi: 10.1212/WNL.0b013e3182535d0c. Review.

8.

Complementary and alternative medicine use among adults with migraines/severe headaches.

Wells RE, Bertisch SM, Buettner C, Phillips RS, McCarthy EP.

Headache. 2011 Jul-Aug;51(7):1087-97. doi: 10.1111/j.1526-4610.2011.01917.x. Epub 2011 Jun 7.

9.
10.

Are the current IHS guidelines for migraine drug trials being followed?

Hougaard A, Tfelt-Hansen P.

J Headache Pain. 2010 Dec;11(6):457-68. doi: 10.1007/s10194-010-0257-5. Epub 2010 Oct 8. Review.

11.

Prophylaxis of migraine headache.

Pringsheim T, Davenport WJ, Becker WJ.

CMAJ. 2010 Apr 20;182(7):E269-76. doi: 10.1503/cmaj.081657. Epub 2010 Feb 16. Review. No abstract available.

12.

New drugs for migraine.

Stovner LJ, Tronvik E, Hagen K.

J Headache Pain. 2009 Dec;10(6):395-406. doi: 10.1007/s10194-009-0156-9. Epub 2009 Oct 1. Review.

13.

The pharmacological management of migraine, part 2: preventative therapy.

Demaagd G.

P T. 2008 Aug;33(8):480-7. No abstract available.

14.

Prophylaxis of migraine: general principles and patient acceptance.

D'Amico D, Tepper SJ.

Neuropsychiatr Dis Treat. 2008 Dec;4(6):1155-67.

15.

Current migraine management - patient acceptability and future approaches.

Fumal A, Schoenen J.

Neuropsychiatr Dis Treat. 2008 Dec;4(6):1043-57.

16.

Chronic disorders with episodic manifestations: focus on epilepsy and migraine.

Haut SR, Bigal ME, Lipton RB.

Lancet Neurol. 2006 Feb;5(2):148-157. doi: 10.1016/S1474-4422(06)70348-9. Review.

Supplemental Content

Support Center